fundvisualizer.com

Sterling Capital Equity Income CBCEGX

Performance (before sales charge)

As of 04/30/2023

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 04/30/2023
Stock
93.41%
Non-U.S. Stock
3.46%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
3.12%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 04/30/2023

Basic materials

2.33%

Consumer cyclical

10.81%

Financial services

23.70%

Real estate

3.13%

Consumer defensive

5.89%

Health care

21.12%

Utilities

0.00%

Communication services

0.00%

Energy

0.00%

Industrials

10.49%

Technology

19.40%

Top 10 holdings

As of 04/30/2023

Microsoft Corp
4.82%
Merck & Co Inc
4.08%
Abbott Laboratories
4.01%
Motorola Solutions Inc
3.97%
Elevance Health Inc
3.90%
Ferguson PLC
3.88%
Marsh & McLennan Companies Inc
3.82%
AbbVie Inc
3.82%
Avery Dennison Corp
3.80%
The Home Depot Inc
3.74%
Fund assets

$2.04 Billion

Share class

C

Morningstar category

Large Value

Expense ratio

1.79%

Investment objective

Equity-Income

Documents